CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents		$ 394,190	$ 497,070
Restricted cash and equivalents	[1]	10,204	10,610
Marketable securities		422,492	411,901
Receivables, net		1,004,856	497,574
Prepaid expenses and other current assets, net		44,697	34,119
Total current assets		1,876,439	1,451,274
Property and equipment, net		22,132	20,050
Intangible assets, net		92,712	67,680
Goodwill		62,140	41,540
Other assets, net		116,846	116,924
Total assets		2,170,269	1,697,468
Current liabilities:
Medical claims and related payables		745,557	346,727
Accounts payable and accrued expenses		222,052	183,364
Current portion of long-term debt		5,000	5,000
Total current liabilities		972,609	535,091
Long-term debt, net of current portion		37,249	38,482
Other liabilities		78,571	83,286
Total liabilities		1,088,429	656,859
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 414,465 and 412,385 shares issued and outstanding, respectively		4,145	4,124
Additional paid-in capital		2,130,126	2,106,886
Accumulated deficit		(1,048,208)	(1,064,230)
Accumulated other comprehensive income (loss)		(3,549)	(5,560)
Total agilon health, inc. stockholders' equity (deficit)		1,082,514	1,041,220
Noncontrolling interests		(674)	(611)
Total stockholders’ equity (deficit)		1,081,840	1,040,609
Total liabilities and stockholders' equity (deficit)		$ 2,170,269	$ 1,697,468

[1] Restricted cash and equivalents primarily consist of amounts used as collateral to secure letters of credit that the Company is required to maintain pursuant to contracts with payors.